Fatima Anjum
SUNY Downstate Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Fatima Anjum.
American Journal of Physiology-lung Cellular and Molecular Physiology | 2011
Calvin Yeang; Sunil Wadgaonkar; Fatima Anjum; Natalia Grinkina; Michael Cutaia; Xian-Chen Jiang; Raj Wadgaonkar
Sphingomyelin synthase (SMS) catalyzes the synthesis of sphingomyelin (SM) and is required for maintenance of plasma membrane microdomain fluidity. Of the two isoforms of mammalian SMS, SMS1 is mostly present in the trans-Golgi apparatus, whereas SMS2 is predominantly found at the plasma membrane. SMS2 has a role in receptor mediated response to inflammation in macrophages, however, the role of SMS2 in vascular permeability, pulmonary edema, and lung injury have not been investigated. To define the role of SMS activation in lung injury, we utilized a lipopolysaccharide (LPS)-induced lung edema model. SMS activity was measured and correlated with the severity of lung injury. Within 4 h of LPS treatment, SMS activity was increased significantly and remained upregulated up to 24 h. Comparison of LPS-induced lung injury in SMS2 knockout (SMS2(-/-)) and wild-type littermate control mice showed that inflammation, cytokine induction, and lung injury were significantly inhibited in SMS2(-/-) mice. Our results suggest that a deficiency of SMS2 can diminish the extent of pulmonary edema and lung injury. Furthermore, we show that depletion of SMS2 was sufficient to decrease MAP kinase-JNK activation, severity of LPS-induced pulmonary neutrophil influx, and inflammation, suggesting a novel role of SMS2 activation in lung injury.
Pulmonary circulation | 2012
Fatima Anjum; Jason Lazar; Joe Zein; Ghassan Jamaleddine; Spiro Demetis; Raj Wadgaonkar
Endothelial dysfunction plays an important role in the pathogenesis of pulmonary arterial hypertension (PAH) in sickle cell disease (SCD). A variety of evidence suggests that circulating endothelial progenitor cells (EPCs) play an integral role in vascular repair. We hypothesized that SCD patients with PAH are deficient in EPCs, potentially contributing to endothelial dysfunction and disease progression. The number of circulating CD34+/CD14-/CD106+ EPCs was significantly lower in SCD patients with PAH than without PAH (P=0.025). CD34+/CD14-/CD106+ numbers significantly correlated with tricuspid regurgitation velocity (TRV, r=−0.44, P=0.033) 6-minute walk distance (6MWD, r= 0.72, P=0.001), mean pulmonary artery pressure (mPAP, r= −0.43, P=0.05), and pulmonary vascular resistance (PVR, r=−0.45, P=0.05). Other EPC subsets including CD31+/CD133+/CD146+ were similar between both groups. Numbers of EPCs did not correlate with age, sex, hemoglobin, WBC count, reticulocyte count, lactate dehydrogenase (LDH), iron/ferritin levels, and serum creatinine. These data indicate that subsets of EPC are lower in SCD patients with PAH than in those without PAH. Fewer EPCs in PAH patients may contribute to the pulmonary vascular pathology. Reduced number of EPCs in SCD patients with PAH might not only give potential insight into the pathophysiological mechanisms but also might be useful for identifying suitable therapeutic targets in these patients.
American Journal of Respiratory Cell and Molecular Biology | 2012
Fatima Anjum; Keval Joshi; Natalia Grinkina; Michael Cutaia; Raj Wadgaonkar
Sphingomyelin (SM), a major sphingolipid in the lipid raft microdomains of the cell membrane, is synthesized by plasma membrane-bound sphingomyelin synthase 2 (SMS2). SMS2 is required for the maintenance of plasma membrane microdomain fluidity and receptor-mediated responses to inflammation in macrophages. However, the exact mechanism of SMS2 activation in endothelial barrier disruption and lung injury is not fully understood. To define the role of SMS activation in lung injury, we hypothesized that the inhibition of SM synthesis may provide protection against acute lung injury (ALI) by preserving endothelial barrier function. Using SMS2-silencing RNA (siRNA) treatment in human pulmonary endothelial cells (HPAECs) and tricyclodecan-9-yl-xanthogenate (D609), a competitive inhibitor of SMS, and phosphatidylcholine-specific phospholipase C in a murine model of bacterial LPS injury, we studied the role of sphingomyelin synthesis in ALI. Results show that pretreating mice with D609 significantly attenuated LPS-induced lung injury, as measured by a significant decrease in wet to dry ratio, bronchoalveolar lavage fluid cell and protein counts, and myeloperoxidase activity in lung tissue. Similarly, LPS-induced endothelial barrier disruption was significantly reduced in HPAECs pretreated with D609 or SMS2 siRNA, as demonstrated by an increase in paracellular integrity on an FITC-dextran assay, by the inhibition of LPS-induced stress fibers, and by the formation of cortical actin rings and lamellipodia at the periphery. These results indicate that D609 attenuates LPS-mediated endothelial barrier dysfunction and lung injury in mice through inhibition of SMS, suggesting a novel and essential role of SMS inhibition in modulating endothelial barrier integrity via actin cytoskeletal activation, with a potential therapeutic role in ALI.
Pulmonary circulation | 2013
Fatima Anjum; Jason Lazar; James Soh; Maher Albitar; M Mahmood Hussain; Raj Wadgaonkar
Pulmonary arterial hypertension (PAH) is a major complication of sickle cell disease (SCD). Low levels of apolipoprotein A1 (Apo-A1) have been implicated in the development of PAH in SCD. We speculate that lower levels of Apo-A1 are related to dysregulation of the ubiquitin-proteasome pathway (UPP). Of 36 recruited patients with SCD, 14 were found to have PAH on the basis of right heart catheterization. Levels of Apo-A1 and Apo-B, polyubiquitin, total protease, and specific and normalized activity of chymotrypsin-like, trypsin-like, and caspase-like proteases in plasma were measured. Levels of Apo-A1 were found to be lower and polyubiquitin levels were found to be significantly higher in the PAH group (P < 0.05) in SCD. Apo-A levels were inversely correlated with polyubiquitin levels (r = −0.499, P = 0.009). These results indicate that lower levels of Apo-A1 in SCD patients with PAH are likely related to enhance degradation by UPP, potentially contributing to pulmonary vascular pathology. These findings may provide significant insight in identifying suitable therapeutic targets in these patients.
Chest | 2010
Fatima Anjum; Keval Joshi; Jason Lazar; Raj Wadgaonkar
(2010). Identification of circulating Endothelial progenitor cells in patients with pulmonary arterial hypertension secondary to sickle cell disease. A case of cryptococcal mediastinitis leading to pulmonary arterial hypertension. Chest, 138(4). (2011). Determination of lipoprotein lipase activity using a novel fluorescent lipase assay. Primary cilia dynamics instruct tissue patterning and repair of corneal endothelium. Ventricular fibrillation effectively treated by wearable automatic defibrillator-A case report. Tobacco use as a prognosticator of other substance use, sexual and physical abuse, and adverse outcome in HIV-positive youth.
Indian Journal of Hematology and Blood Transfusion | 2011
Keval Joshi; Fatima Anjum; Dushyant Damania; Suzette Graham-Hill; Peter Gillette; Joe Zein; Ghassan Jamaleddine; Spiro Demetis; Raj Wadgaonkar
StatPearls | 2017
Sikander Zulqarnain; Fatima Anjum; Tracy Macaulay; Marintha Short; Aimon Miranda
StatPearls | 2017
Sikander Zulqarnain; Fatima Anjum; Rhonda Coffman; Lindsay Iverson; Heather Templin
Chest | 2013
Kerwin Cumberbatch; Fatima Anjum; Louis Rolston-Cregler; Nadia Morgan; Muhammad Mansoor Khan
american thoracic society international conference | 2012
Raj Wadgaonkar; Fatima Anjum